Total Funding
40
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
91281
Gala Therapeutics is a privately-held medical device company developing disease-modifying therapies to improve survival for patients.
Acquired by 
Galvanize Therapeutics
James Stambaugh: Senior Vice President, Clinical Affairs & StrategyPast Role: Intersect ENT, Vice President, Clinical Affairs and Reimbursement
Michelle L. Machuca: Sr. Director, Market AccessPast Role: TVA Medical, Director of Marketing and Reimbursement
About the Company
Gala Therapeutics is a privately-held medical device company developing disease-modifying therapies to improve survival for patients with pulmonary diseases. Its therapies address the needs of interventional pulmonologists, thoracic surgeons, and physicians who treat a pulmonary disease that enables them to treat their patients better, resulting in
a better medical outcome.
It was founded in 2015 and is headquartered in Menlo Park, California.
